Patent · US Active

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

US11602513B1 · kind B1 · utility

33Cited by

257References

27Claims

0Family size

Assignee

Flamel Ireland Limited · IE

Inventors

Jordan Dubow · Chicago, US
Hervé Guillard · Villeurbanne, FR
Claire Mégret · L'Essart Mador, FR
Jean-François Dubuisson · L'Essart Mador, FR

Key dates

Filing date	Oct 8, 2021
Grant date	Mar 14, 2023
Priority date	—
Expiry date	Oct 8, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/5047
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.